GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test
At DNA Labs UAE, we offer the GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test. This test is designed to diagnose individuals suspected of having hemolytic anemia due to glucose phosphate isomerase deficiency.
Test Details
The GPI gene is responsible for producing an enzyme called glucose phosphate isomerase (GPI). Hemolytic anemia refers to a condition where red blood cells are destroyed faster than they can be replaced, leading to a shortage of healthy red blood cells. Nonspherocytic anemia means that the red blood cells are not abnormally shaped (as is the case in spherocytic anemia). Glucose phosphate isomerase deficiency is a rare genetic disorder that results from mutations in the GPI gene. These mutations lead to reduced or absent GPI enzyme activity, which is essential for the normal function of red blood cells. Without sufficient GPI enzyme activity, red blood cells are more prone to destruction, leading to hemolytic anemia.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hematology
- Doctor: Hematologist
- Test Department: Genetics
Pre Test Information
Before undergoing the GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency.
Test Method
NGS (Next-Generation Sequencing) genetic testing is used to analyze the DNA sequence of an individual’s genes. This technique can identify specific mutations or variants in the GPI gene associated with glucose phosphate isomerase deficiency. NGS genetic testing allows for the detection of a wide range of genetic variations quickly and efficiently.
Importance of the Test
By performing NGS genetic testing on an individual suspected of having hemolytic anemia due to glucose phosphate isomerase deficiency, healthcare professionals can confirm the diagnosis and provide appropriate treatment and management strategies. Early detection and intervention can greatly improve the quality of life for individuals with this genetic disorder.
For more information or to schedule an appointment for the GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test, please contact DNA Labs UAE.
| Test Name | GPI Gene Hemolytic anemia nonspherocytic due to glucose phosphate isomerase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hematology |
| Doctor | Hematologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GPI Gene Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GPI Gene Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency NGS Genetic DNA Test gene GPI |
| Test Details | The GPI gene is responsible for producing an enzyme called glucose phosphate isomerase (GPI). Hemolytic anemia refers to a condition where red blood cells are destroyed faster than they can be replaced, leading to a shortage of healthy red blood cells. Nonspherocytic anemia means that the red blood cells are not abnormally shaped (as is the case in spherocytic anemia). Glucose phosphate isomerase deficiency is a rare genetic disorder that results from mutations in the GPI gene. These mutations lead to reduced or absent GPI enzyme activity, which is essential for the normal function of red blood cells. Without sufficient GPI enzyme activity, red blood cells are more prone to destruction, leading to hemolytic anemia. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of an individual’s genes. It can identify specific mutations or variants in the GPI gene associated with glucose phosphate isomerase deficiency. This testing method allows for the detection of a wide range of genetic variations quickly and efficiently. By performing NGS genetic testing on an individual suspected of having hemolytic anemia due to glucose phosphate isomerase deficiency, healthcare professionals can confirm the diagnosis and provide appropriate treatment and management strategies. |
